NasdaqCM - Delayed Quote USD

NeuroSense Therapeutics Ltd. (NRSNW)

0.4840
+0.1440
+(42.35%)
At close: May 30 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
9,902
9,902
12,049
10,554
5,587
Operating Income
-9,902
-9,902
-12,049
-10,554
-5,587
Net Non Operating Interest Income Expense
-309
-309
-270
84
-1,154
Other Income Expense
1
1
2,212
-22
2,700
Pretax Income
-10,210
-10,210
-10,107
-10,492
-4,041
Net Income Common Stockholders
-10,210
-10,210
-10,107
-10,492
-4,041
Diluted NI Available to Com Stockholders
-10,210
-10,210
-10,107
-10,492
-4,041
Total Operating Income as Reported
-9,902
-9,902
-12,049
-10,554
-5,587
Total Expenses
9,902
9,902
12,049
10,554
5,587
Net Income from Continuing & Discontinued Operation
-10,210
-10,210
-10,107
-10,492
-4,041
Normalized Income
-10,211
-10,211
-12,319
-10,470
-6,741
Interest Income
2
2
178
91
0
Interest Expense
--
--
11
15
0
Net Interest Income
-309
-309
-270
84
-1,154
EBIT
-9,902
-9,902
-12,049
-10,554
-4,041
EBITDA
-9,880
-9,880
-12,028
-10,542
-4,038
Reconciled Depreciation
22
22
21
12
3
Net Income from Continuing Operation Net Minority Interest
-10,210
-10,210
-10,107
-10,492
-4,041
Total Unusual Items Excluding Goodwill
1
1
2,212
-22
2,700
Total Unusual Items
1
1
2,212
-22
2,700
Normalized EBITDA
-9,881
-9,881
-14,240
-10,520
-6,738
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NLSPW NLS Pharmaceutics AG
0.0289
+42.36%
 
4XC1.SG KalVista Pharmaceuticals Inc
10.30
+0.98%
 
IMTXW Immatics N.V.
0.0131
0.00%
 
7RG0.F Regulus Therapeutics Inc.
6.85
-2.14%
 
GNNSF Genscript Biotech Corporation
1.3550
+4.23%
 
CDTTW Conduit Pharmaceuticals Inc.
0.0107
-1.83%
 
RCKTW Rocket Pharmaceuticals, Inc.
0.0310
-20.10%
 
LEXXW Lexaria Bioscience Corp.
0.1600
-20.00%
 
GOVXW GeoVax Labs, Inc.
0.0336
-1.18%
 
ATNFW 180 Life Sciences Corp.
0.0080
+6.67%